T., Lines, R., Levine, N., Brooks, C., Xiang, L., Hruby, V
Chronic conditions The risk of deficiency is higher for those with diseases like cirrhosis and kidney disease
FDA-approved peptide therapies used as directed have established safety profiles
For additional information, please visit www.americanregent.com
It now sits within a growing gray-market peptide ecosystem that includes compounds such as BPC-157 (marketed for healing and recovery), TB-500 (muscle repair), KPV (anti-inflammatory use), MOTS-c (metabolic performance), Epitalon (anti-aging), Semax (cognitive enhancement), DSIP (sleep and recovery), and Melanotan II itself, despite limited clinical evidence and lack of regulatory approval
For procedures in which complications are catastrophic, including TJA, counseling should prioritize discontinuation of nonessential injectable biologics before surgery, explicit documentation of exposure, and heightened vigilance for early wound complications